Cirrhosis 发表于 2025-3-25 07:02:42

http://reply.papertrans.cn/2/123/12284/12284-21.png

直觉好 发表于 2025-3-25 10:30:21

http://reply.papertrans.cn/2/123/12284/12284-22.png

Chronic 发表于 2025-3-25 15:43:30

Submitted on: 22 February 2010.
Revised on: 05 May 2010.
Accepted on: 01 June 2010.

___________________IMMUNOLOGICAL INVESTIGATIONS---TAYLOR & FRANCIS INC

Adherent 发表于 2025-3-25 16:40:59

Submitted on: 27 August 2020.
Revised on: 03 October 2020.
Accepted on: 24 October 2020.

___________________IMMUNOLOGICAL INVESTIGATIONS---TAYLOR & FRANCIS INC

Nonconformist 发表于 2025-3-25 21:41:19

http://reply.papertrans.cn/2/123/12284/12284-25.png

Substance-Abuse 发表于 2025-3-26 01:56:56

Submitted on: 29 June 2024.
Revised on: 20 October 2024.
Accepted on: 15 November 2024.

___________________IMMUNOLOGICAL INVESTIGATIONS---TAYLOR & FRANCIS INC

接合 发表于 2025-3-26 08:17:06

Submitted on: 07 April 2002.
Revised on: 14 May 2002.
Accepted on: 14 June 2002.

___________________IMMUNOLOGICAL INVESTIGATIONS---TAYLOR & FRANCIS INC

下垂 发表于 2025-3-26 08:51:47

http://reply.papertrans.cn/2/123/12284/12284-28.png

endarterectomy 发表于 2025-3-26 12:58:30

Submitted on: 10 March 2012.
Revised on: 25 May 2012.
Accepted on: 15 July 2012.

___________________IMMUNOLOGICAL INVESTIGATIONS---TAYLOR & FRANCIS INC

alabaster 发表于 2025-3-26 20:31:30

Submitted on: 12 August 2016.
Revised on: 02 November 2016.
Accepted on: 24 November 2016.

___________________IMMUNOLOGICAL INVESTIGATIONS---TAYLOR & FRANCIS INC
页: 1 2 [3] 4
查看完整版本: SCIE期刊IMMUNOLOGICAL INVESTIGATIONS 2024/2025影响因子:2.927 (IMMUNOL INVEST) (0882-0139). (IMMUNOLOGY)(免疫学)Science Citation